LEO bulks up with deal for Boehringer skin drug LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

#dermatology #LEO #Boehringer #LEOPharma #psoriasis #BoehringerIngelheim #Spevigo #spesolimab #IL36inhibitor #psoriasisflares #generalisedpustularpsoriasis #GPP #IL36mediatedskindiseases #palmoplantarpustulosis #hidradenitissuppurativa #congenitalichthyosis
pharmaphorum.com/news/leo-bul...